Search

everythinglearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Rats had lasting erectile problems after stopping a certain medication.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride for hair loss may cause gynecomastia; doctors should inform patients.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Hormonal therapies might help treat hidradenitis suppurativa, but treatment is complex and personalized.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Recent advances in hair loss treatments show significant progress.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

The method effectively measures drug impact on DHT levels in prostate treatments.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The equine epididymis mainly uses type 1 5α-reductase, and both finasteride and dutasteride can inhibit its activity.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.